Ibere Pharmaceuticals Cl A (IBER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2006 | |
| Cash Flows From Operating Activities | |||
| Net Income | 1,562 | -6 | N/A |
| Other Working Capital | 135 | 2 | N/A |
| Other Operating Activity | -2,566 | 0 | 0 |
| Operating Cash Flow | $-869 | $-4 | $N/A |
| Cash Flows From Investing Activities | |||
| Purchase Of Investment | -138,000 | 0 | N/A |
| Investing Cash Flow | $-138,000 | $0 | $N/A |
| Cash Flows From Financing Activities | |||
| Change In Short Term Borrowing | 31 | 169 | N/A |
| Common Stock Issued | 140,075 | 25 | N/A |
| Other Financing Activity | -954 | -15 | 0 |
| Financing Cash Flow | $139,152 | $179 | $N/A |
| Beginning Cash Position | 175 | N/A | N/A |
| End Cash Position | 458 | 175 | N/A |
| Net Cash Flow | $283 | $175 | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -869 | -4 | N/A |
| Free Cash Flow | -869 | -4 | 0 |